Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 457,642 | 439,664 | 414,602 | 427,687 | 304,399 |
| Cost of Goods | 39,613 | 29,055 | 30,169 | 20,145 | 21,843 |
| Gross Profit | 418,029 | 410,609 | 384,433 | 407,542 | 282,556 |
| Operating Expenses | 260,539 | 257,614 | 238,932 | 205,323 | 195,921 |
| Operating Income | 158,103 | 153,050 | 145,670 | 202,364 | 87,478 |
| Interest Expense | 11,365 | 11,675 | 11,495 | 11,413 | 11,236 |
| Other Income | 954 | 456 | 384 | 517 | 501 |
| Pre-tax Income | 147,692 | 141,831 | 134,559 | 191,468 | 76,743 |
| Income Tax | 60,316 | 42,957 | N/A | N/A | N/A |
| Net Income Continuous | 87,376 | 98,874 | 470,407 | 191,468 | 76,743 |
| Net Income | $87,376 | $98,874 | $470,407 | $191,468 | $76,743 |
| EPS Basic Total Ops | 0.89 | 1.02 | 4.97 | 2.02 | 0.81 |
| EPS Basic Continuous Ops | 0.89 | 1.02 | 4.97 | 2.02 | 0.81 |
| EPS Diluted Total Ops | 0.79 | 0.90 | 4.22 | 1.72 | 0.70 |
| EPS Diluted Continuous Ops | 0.79 | 0.90 | 4.04 | 1.65 | 0.70 |
| EBITDA(a) | $167,805 | $162,457 | $155,448 | $211,693 | $96,895 |